Loading…
Entera Bio Ltd. is projected to rise to $3.35 by 2027, a +12% move from its current price of $2.99. ENTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $2.82 | $2.99 | $3.18 | +0.05% |
| Aug 5 | $2.75 | $2.99 | $3.26 | +0.09% |
| Aug 6 | $2.70 | $2.99 | $3.32 | +0.14% |
| Aug 7 | $2.66 | $3.00 | $3.38 | +0.18% |
| Aug 8 | $2.62 | $3.00 | $3.43 | +0.23% |
| Aug 9 | $2.59 | $3.00 | $3.47 | +0.28% |
| Aug 10 | $2.56 | $3.00 | $3.52 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.56 | $3.00 | $3.52 | +0.32% |
| Week 2 | $2.40 | $3.01 | $3.77 | +0.65% |
| Week 3 | $2.29 | $3.02 | $3.97 | +0.97% |
| Week 4 | $2.21 | $3.03 | $4.16 | +1.30% |
| Week 5 | $2.13 | $3.04 | $4.33 | +1.63% |
| Week 6 | $2.07 | $3.05 | $4.50 | +1.95% |
| Week 7 | $2.01 | $3.06 | $4.65 | +2.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Entera Bio Ltd. is a clinical stage healthcare company that develops oral peptides and protein replacement therapies in Israel and internationally. It focuses on EB613, an oral teriparatide, EB612, a tablet peptide replacement therapy, EB618, a GLP-1/glucagon dual agonist peptide, and GLP-2 in Phase I clinical trial for various indications.
The company has a collaboration agreement with OPKO Biologics, Inc for the preclinical and clinical development of LA-PTH and oral dual agonist GLP-1/glucagon peptide. Entera Bio was incorporated in 2009 and is based in Jerusalem, Israel.
Entera Bio Ltd. (ENTX) is a healthcare stock with a current price of $3.00. The symbol for the asset is ENTX. The stock has a market cap of $147.87M and is ranked 3993 in market listings.
Forecasts show an upward price path over time, with the average price rising from $3.00 in 2026 to $29.94 in 2050 and a max forecast of $68.87 in 2050. The sentiment in the forecast turns Bullish by 2029 and remains Bullish thereafter, with Neutral readings in the early years.
A major floor 66.6% below — a decisive break under it would weaken the trend.
The nearest floor, 59.5% below — buyers have tended to step in here.
The nearest ceiling, 31.1% above — a clean break opens room to run.
A major ceiling 81.2% above — clearing it would confirm fresh momentum.
Key ENTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.22 | Sell | $2.94 | Buy |
| MA 10 | $2.63 | Buy | $2.70 | Buy |
| MA 20 | $2.19 | Buy | $2.35 | Buy |
| MA 50 | $1.68 | Buy | $1.88 | Buy |
| MA 100 | $1.44 | Buy | $1.67 | Buy |
| MA 200 | $1.70 | Buy | $1.67 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 65.22 | Neutral |
| Stoch RSI (14) | 21.66 | Neutral |
| CCI (20) | 103.28 | Buy |
| Williams %R (14) | -40.43 | Info |
| MACD (12,26,9) | 0.10 | Buy |
| ROC (12) | 67.98 | Buy |
| Bollinger %B (20,2) | 0.81 | Neutral |
| Stochastic %K (14) | 59.57 | Neutral |
| TRIX (15) | 2.65 | Buy |
| Awesome (5,34) | 1.34 | Buy |
| Ultimate (7,14,28) | 66.79 | Neutral |
| Momentum (10) | 1.01 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 3.28 | Sell |
| ADX (14) | 34.80 | Buy |
| ATR (14) | 0.20 | Info |
The 30-day technical picture is bullish, with RSI14 at 70. The stock trades above its key moving averages, with SMA50 at $1.61 and SMA200 at $1.70. The price faces a resistance level at $3.92 and a support level at $1.18, forming a framework for near-term moves.
The 30-day range runs from $1.97 to $4.57, and the current price of $3.00 sits within that range. The stock shows an annualized volatility of 100, underscoring elevated short-term risk.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.00 | $2.99 | $3.95 | 0% | Neutral | |
| $2.44 | $3.35 | $4.97 | +12% | Neutral | |
| $2.57 | $3.75 | $5.94 | +25% | Bullish | |
| $2.78 | $4.28 | $7.11 | +43% | Bullish | |
| $3.62 | $5.84 | $10.11 | +95% | Bullish | |
| $5.09 | $8.59 | $15.40 | +187% | Bullish | |
| $5.33 | $9.38 | $17.34 | +214% | Bullish | |
| $5.25 | $9.61 | $18.27 | +222% | Bullish | |
| $5.37 | $10.24 | $19.96 | +242% | Bullish | |
| $4.85 | $9.62 | $19.18 | +222% | Bullish | |
| $9.93 | $22.06 | $48.39 | +638% | Bullish | |
| $17.04 | $37.86 | $87.08 | +11.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.00 | $2.99 | $3.58 | +0.00% |
| September 2026 | $2.46 | $2.99 | $3.80 | +0.12% |
| October 2026 | $2.53 | $3.12 | $4.04 | +4.16% |
| November 2026 | $2.41 | $3.00 | $3.95 | -3.71% |
| December 2026 | $2.35 | $2.96 | $3.95 | -1.37% |
Click any year to see its month-by-month ENTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ENTX to range from $1.00 to $3.95 through 2026. The $2.99 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ENTX price prediction for 2027 points to an average of $3.35 (low $2.44, high $4.97) — a potential gain of +12% on today's $2.99. A consolidation phase looks the most probable path here.
In 2028, ENTX is projected to trade between $2.57 and $5.94, averaging $3.75 — a potential gain of +25% from today's $2.99. That is up +12% on the projected 2027 average. Momentum favours further upside here.
Entera Bio Ltd.'s 2029 outlook centres on $4.28, within a $2.78 to $7.11 range. That is up +14% on the projected 2028 average. That marks a +43% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ENTX could reach as high as $10.11, with a base case around $5.84 and support toward $3.62 — roughly +95% from $2.99. Momentum favours further upside here.
Expect ENTX to range from $5.09 to $15.40 through 2031. The $8.59 average target implies a +187% move from current prices. That is up +47% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ENTX price prediction for 2032 points to an average of $9.38 (low $5.33, high $17.34) — a potential gain of +214% on today's $2.99. Momentum favours further upside here.
In 2033, ENTX is projected to trade between $5.25 and $18.27, averaging $9.61 — a potential gain of +222% from today's $2.99. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
Entera Bio Ltd.'s 2034 outlook centres on $10.24, within a $5.37 to $19.96 range. That is up +7% on the projected 2033 average. That marks a +242% change versus current levels. Momentum favours further upside here.
By 2035, ENTX could reach as high as $19.18, with a base case around $9.62 and support toward $4.85 — roughly +222% from $2.99. Buyers look set to stay in control over this stretch.
Expect ENTX to range from $9.93 to $48.39 through 2040. The $22.06 average target implies a +638% move from current prices. That is up +129% on the projected 2035 average. Momentum favours further upside here.
The ENTX price prediction for 2050 points to an average of $37.86 (low $17.04, high $87.08) — a potential gain of +11.7x on today's $2.99. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENTX today (≈ 334.448161 ENTX) could be worth
$12,662.18
+$11,662.18 (+1166%) by 2050 · US Dollar
Based on the average projected ENTX price of $37.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENTXwould be worth at today's price.
$1,000 invested in ENTX on Jul 31, 2025 (≈ 518.134729 ENTX) would be worth
$1,549.22
+$549.22 (+54.9%) today · 1.55× · US Dollar
Based on a ENTX entry price of $1.93 vs. today's $2.99.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.05 | $1,458.54 | +45.9% |
| 1 month ago | $1.69 | $1,769.23 | +76.9% |
| 3 months ago | $1.1 | $2,718.18 | +171.8% |
| 6 months ago | $1.33 | $2,248.12 | +124.8% |
| 1 year ago | $1.93 | $1,549.22 | +54.9% |
| All time (5.0y) ago | $4.92 | $607.72 | -39.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENTX forecast.
Our base-case forecast reaches $6.00 around 2031.
Implied market cap at $6.00: $295.74M
The multi-year forecast shows a meaningful upside trajectory. In 2026 the min is $1.00, the avg is $3.00, and the max is $3.96, with ROI 0 and Neutral sentiment. In 2027 the min is $2.39, the avg is $3.29, and the max is $4.88, with ROI 9.6 and Neutral sentiment.
In 2028 the min is $2.40, the avg is $3.51, and the max is $5.56, with ROI 17 and Neutral sentiment. In 2029 the min is $2.57, the avg is $3.95, and the max is $6.57, with ROI 31.7 and Bullish sentiment.
Tap a question to reveal the answer.
The 2030 forecast shows min $3.25, avg $5.25, max $9.09, with ROI 74.9% and Bullish sentiment.
Forecasts show a progression from Neutral in 2026 to Bullish in 2029 and beyond, with ROI climbing to a peak of 898.1% in 2050 and a max price of $68.87 in 2050.
Yes. The max forecast reaches $13.64 in 2031, while 2030 max is $9.09, indicating ENTX could exceed $10 in 2031 according to the forecast.
Current price is $3.00 and market cap is $147.87M.
The 30-day range is $1.97 to $4.57.
Entera Bio Ltd. Community Discussion
0Share your Entera Bio Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.